DOSSIER · UPDATED 18 NOV 2025

Obsidian Therapeutics

Obsidian Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops adoptive cell therapies for the treatment of patient with cancer diseases. Obsidian Therapeutics serves customers in the State of…

obsidiantx.com ↗Claim this profile
Founded
2015
Headcount
111
Open roles
9
Last raised
Series C · $161M
SECTION I · THE BRIEF

Inside Obsidian Therapeutics

Brief #13081Updated 18 NOV 2025CAMBRIDGEGVSERIES C
Employbl Dossier

Obsidian Therapeutics

Obsidian Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops adoptive cell therapies for the treatment of patient with cancer diseases. Obsidian Therapeutics serves customers in…

Founded
2015
Headcount
111
Open roles
9
Last raised
Series C · $161M
Section II — RestrictedMembers only
  • Engineering interview process at Obsidian Therapeutics
  • Tech stack & infrastructure choices
  • Culture & day-to-day work style
  • Why join now vs. 6 months from now
  • Hiring focus & open headcount by team
  • Comp philosophy and band context
Open Obsidian Therapeutics briefSign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Tariq KassumTariq Kassum
Steve ShamahSteve Shamah
Michael GilmanMichael Gilman
OPEN ROLES

Hiring at Obsidian Therapeutics

Current Job Listings

Listing 0 of 9 job openings
    FUNDING

    Capital raised

    Total Amount Raised: $325,000,000

    Obsidian Therapeutics' Investors

    Obsidian Therapeutics Funding Rounds

    • Series C

      $160,500,000

    • Series C

      $160,500,000

      Series C Investors

      Wellington Management
      Foresite Capital
      RTW Investments
      Novo Holdings
      Henderson Global Investors
      Woodline Partners
      Atlas Venture
      Paradigm BioCapital Advisors
      Bristol-Myers Squibb Company
      Samsara BioCapital
      RA Capital Management
      Blue Owl
      Deep Track Capital
      Surveyor Capital
      Logos Capital
      TCGX
      T. Rowe Price

    • Series B

      $115,000,000

    • Series B

      $115,000,000

      Series B Investors

      The Column Group
      Pivotal bioVenture Partners
      Soleus Capital
      COWEN
      Surveyor Capital
      Samsara BioCapital
      Deep Track Capital
      Logos Capital
      RA Capital Management
      Atlas Venture
      Bristol-Myers Squibb Company
      Amgen
      Vertex Ventures HC
      TCGX

    • Series A

      $49,500,000

    • Series A

      $49,500,000

      Series A Investors

      GV
      Takeda Ventures
      Atlas Venture
      Amgen
      ShangPharma
      Alexandria Venture Investments
      Vertex Ventures HC
      Vertex Ventures
      Vertex Pharmaceuticals
    Funding info provided by Diffbot.
    TAGS

    Categorized in

    Company Collections

    These are collections Obsidian Therapeutics is a part of. Click on the collection name to view similar companies.

    Obsidian Therapeutics' Investors

    Obsidian Therapeutics' Industries

    Obsidian Therapeutics' Tech Stack

    LOCATIONS

    Where they work

    Obsidian Therapeutics Headquarters Location

    1030 Massachusetts Avenue suite 400, Cambridge, MA, 02138

    Loading map…